Watch for Ibsrela for Irritable Bowel Syndrome

New Rx Ibsrela (tenapanor) will soon hit shelves for irritable bowel syndrome with constipation (IBS-C) in adults.

You'll hear that Ibsrela is the first "NHE3 (sodium/hydrogen exchanger 3) inhibitor" for IBS-C.

It's touted to have a "triple action" that blocks dietary sodium absorption...improves leaky gut...and reduces visceral hypersensitivity, or pain-sensing nerve activity in the GI tract.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote